1. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer
   You-Wei Zhang et al, 2014, Epigenetics CrossRef
2. Wnt signaling pathway in non-small cell lung cancer.
   David J Stewart, 2014, J Natl Cancer Inst CrossRef
3. Wnt signaling as potential therapeutic target in lung cancer
   Jiali Yang et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
4. PORCN Moonlights in a Wnt-Independent Pathway That Regulates Cancer Cell Proliferation
   Tracy M. Covey et al, 2012, PLoS ONE CrossRef
5. Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer
   WEN TIAN et al, 2016 CrossRef
6. Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma.
   Babett Bartling et al, 2011, Mol. Med. CrossRef
7. Application of porcupine inhibitors in stem cell fate determination
   Ashkan Kalantary‐Charvadeh et al, 2020, Chem Biol Drug Des CrossRef
8. The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases
   Zeeshan Sattar et al, 2021, Pulmonary Medicine CrossRef
9. Porcn as a novel therapeutic target in cancer therapy:  A review
   Mortaza Raeisi et al, 2022, Cell Biology International CrossRef
10. Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma
    Lien Provez et al, 2023, Cancers CrossRef
11. The role of Evi/Wntless in exporting Wnt proteins
    Lucie Wolf et al, 2023 CrossRef